$1.09
-0.04 (-3.54%)
Open$1.10
Previous Close$1.13
Day High$1.15
Day Low$1.05
52W High$5.07
52W Low$0.99
Volume—
Avg Volume85.6K
Market Cap10.45M
P/E Ratio—
EPS$-1.91
SectorBiotechnology
Analyst Ratings
Buy
9 analysts
Price Target
+2,824.8% upside
Current
$1.09
$1.09
Target
$31.88
$31.88
$19.01
$31.88 avg
$45.37
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 188.0K | 888.3K | 5.21M |
| Net Income | -18,309,461 | -77,875,779 | -195,079 |
| Profit Margin | -9,756.5% | -9,268.7% | -3.8% |
| EBITDA | -19,939,697 | -89,521,323 | -244,954 |
| Free Cash Flow | — | — | -167,798 |
| Rev Growth | -78.8% | -78.8% | -0.3% |
| Debt/Equity | — | — | 1.55 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |